Benchmark Holdings (BMK)

Sector:

Pharma and Biotech

23.80p
   
  • Change Today:
      1.80p
  • 52 Week High: 45.85
  • 52 Week Low: 17.70
  • Currency: UK Pounds
  • Shares Issued: 741.51m
  • Volume: 2,445,829
  • Market Cap: £176.48m
  • Beta: 0.02

Benchmark Holdings puts itself up for sale, shares jump

By Benjamin Chiou

Date: Monday 22 Jan 2024

LONDON (ShareCast) - (Sharecast News) - Shares in Benchmark Holdings jumped on Monday after the UK-listed aquaculture services group kickstarted a formal sales process
"The board believes that the current share price materially undervalues the combined value of Benchmark's businesses and the long-term prospects of the company, which may at least in part be due to the tightly held and illiquid nature of its ordinary shares," Benchmark said in a statement.

The company, which is a aquaculture genetics, nutrition, and health business, delivering biotechnology products and solutions to the aquaculture industry, said it is not yet in discussions with any parties and highlighted to shareholders that it cannot promise a sale would happen.

Benchmark Holdings floated on the AIM market in December 2013 but has seen its share price slide over 50% since then, even after Monday's 18% surge. The stock currently trades at 41.26p, giving a market capitalisation of just over £300m.

For its most recent financial year, ended 30 September 2023, Benchmark delivered 7% revenue growth, a 15% increase in adjusted EBITDA and improved its operational cash conversion from 35% to 58%, "demonstrating continued progress in the year despite challenging conditions in the shrimp sector, one of the company's core markets", it said.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

BMK Market Data

Currency UK Pounds
Share Price 23.80p
Change Today 1.80p
% Change 8.18 %
52 Week High 45.85
52 Week Low 17.70
Volume 2,445,829
Shares Issued 741.51m
Market Cap £176.48m
Beta 0.02

BMK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
65.89% above the market average65.89% above the market average65.89% above the market average65.89% above the market average65.89% above the market average
95.74% above the sector average95.74% above the sector average95.74% above the sector average95.74% above the sector average95.74% above the sector average
Price Trend
75.17% below the market average75.17% below the market average75.17% below the market average75.17% below the market average75.17% below the market average
40.43% below the sector average40.43% below the sector average40.43% below the sector average40.43% below the sector average40.43% below the sector average
Income Not Available
Growth
57.38% below the market average57.38% below the market average57.38% below the market average57.38% below the market average57.38% below the market average
80.65% below the sector average80.65% below the sector average80.65% below the sector average80.65% below the sector average80.65% below the sector average

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

BMK Dividends

No dividends found

Trades for 23-May-2025

Time Volume / Share Price
13:13 4,131 @ 23.80p
13:13 55,387 @ 23.80p
13:13 132,113 @ 23.80p
12:36 33,333 @ 23.80p
11:32 30,000 @ 23.75p

BMK Key Personnel

CFO Septima Maguire
CEO Trond Williksen
Chair Tripp Lane

Top of Page